donnie

The event served as a dynamic platform to showcase IM8’s forward-thinking approach to wellness, as well as its mission to make elite health and science-backed wellness solutions accessible to all. Among the high-profile attendees were IM8’s co-founding partner, David Beckham, fitness expert Kendall Toole, personal fitness coach Bobby Rich, along with creators from TikTok and Meta including Tavi Castro, Ken Rideout and Jaclyn Savage; and IM8 Scientific Advisory Board members Dr. Amy Shah, Dr. James DiNicolantonio, Dr. Jeremy London and Dr. Jim Green. An Evening of Wellness and FlavorThe night was filled with inspiring conversations and experiences, groundbreaking wellness insights, and unforgettable interactions. Notable highlights included David Beckham’s reflections on his personal wellness journey, as well as his ongoing partnership with IM8. “It’s been great to hear about all the ways in which IM8 is making a big difference in our customer’s lives,” said David Beckham. “For me, I’ve been taking IM8 for almost a year – my energy and focus has completely changed – I feel sharper every day.” Kendall Toole, renowned for her work in fitness, shared her thoughts on the importance of embracing routine into daily life to support wellness goals, while Dr. Amy Shah, Dr. Jeremy London and Dr. James DiNicolantonio joined a panel discussing the science of longevity and how people can focus not only on extending lifespan, but also the quality of life known as healthspan. Dr. Jim Green, former Chief Scientist at NASA and IM8 Scientific Advisory Board Member, presented details on IM8’s ongoing experiment studying advanced aging in space aboard the International Space Station with SpaceX, in partnership with Oxford University. He shared a look at what’s to come with the subsequent experiment launching into orbit on April 21, 2025. The event also provided attendees with an opportunity to explore IM8’s flagship product, Daily Ultimate Essentials, through a medley of creative and flavorful wellness elixirs. Celebrating the Power of CommunityA key theme of the evening was the strength of the IM8 ambassador and creator community, which continues to grow and inspire individuals to live healthier, more energized lives. The creators from platforms like TikTok and Meta demonstrated their passion for wellness and engagement with their audiences, amplifying IM8’s mission to make wellness an accessible part of modern life. “IM8 has always been about pushing the boundaries of wellness, and the Vibrante Miami event proved just how far we’ve come,” said Danny Yeung, CEO of IM8. “The energy in the room was incredible, and it was inspiring to see how our community of doctors, experts, influencers, and creators are shaping the future of health and wellness.” About IM8IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health.

CHARLOTTE, N.C., June 26, 2025 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company, announced today at a special event at Wimbledon House that IM8, its premium supplements brand co-founded by David Beckham, has partnered with world No. 1 tennis star Aryna Sabalenka as its newest global ambassador and shareholder. The announcement comes just days before the start of Wimbledon on June 30th, where Sabalenka will be competing as one of the tournament favorites. The partnership marks a significant milestone for both Sabalenka and IM8, as this represents the first time the tennis champion has endorsed a supplement brand. The collaboration was born organically after Sabalenka experienced remarkable benefits from using IM8’s Daily Ultimate Essentials, which is NSF Certified for Sport®, since the beginning of 2025. Sabalenka, who is preparing for Wimbledon after an impressive first half of 2025 that saw her claim three prestigious titles in Brisbane, Miami, and Madrid, has reported significant improvements in energy, endurance, digestion, and cognitive focus since incorporating IM8 into her daily routine. Her entire team, including her tennis coaches and personal trainer, have also become regular users of the product. “As a professional athlete, I’m extremely cautious about what I put in my body. I’ve tried countless supplements and naturally am always skeptical. Trust is everything,” said Sabalenka. “After my coach recommended IM8, I noticed a difference within weeks – better energy throughout long matches, faster recovery, and improved focus when it matters most. What truly won me over was their deep scientific advisory board with experts from Mayo Clinic and other leading institutions, combined with the fact that IM8 is NSF Certified for Sport®. This gives me absolute confidence in its purity, quality, and scientific foundation. This partnership goes far beyond a typical endorsement – I’ve become a shareholder in Prenetics because I genuinely believe in what this product delivers. Being part of a brand co-founded by David Beckham, who understands the demands of elite sports at the highest level, makes this even more special. The results I’ve experienced firsthand have transformed my approach to optimal nutrition.” Sabalenka added, “While being constantly on the road, it’s incredibly valuable knowing that IM8 can replace 16 supplements with clinical dosages– it’s simplified my nutrition regimen while ensuring I get everything I need. It’s become an essential part of my daily routine and my entire team’s regimen as well. I’m truly excited about the entire IM8 team and what they’re building – their commitment to quality and innovation in supplements is something I wanted to be part of beyond just being an ambassador.” “I’m absolutely thrilled to welcome Aryna to the IM8 family – not just as our global ambassador, but as a shareholder who truly believes in what we’re building,” said Danny Yeung, CEO of Prenetics, the parent company of IM8. “What makes this partnership extraordinary is that Aryna’s journey with IM8 began organically through her performance coach, experiencing the benefits firsthand as a genuine customer before we ever discussed an official relationship. Aryna represents the pinnacle of athletic excellence, mental strength, and professionalism – qualities that perfectly align with our brand values. When an athlete of her caliber not only uses the product but also invests in the company, it speaks volumes about the quality and efficacy of what we’ve created. Her authentic experience and passionate advocacy for IM8 reinforces our mission to provide premium, science-backed supplements that deliver real results for everyone from elite athletes to everyday health enthusiasts.” The partnership comes at a time when supplement safety and quality are increasingly important topics in professional tennis. Recent high-profile cases have highlighted the risks athletes face with contaminated supplements, making IM8’s NSF Certified for Sport® designation particularly significant. This certification ensures that products are regularly tested for more than 280 substances prohibited in sport and confirms that they contain the ingredients listed on the label without unsafe levels of contaminants. Since its launch in December 2024, IM8 has experienced extraordinary growth, achieving US$50m+ Annual Recurring Revenue and serving more than 60,000 customers and delivering over 5 million servings of its premium supplements. This remarkable trajectory places IM8 among the fastest growing supplement brands globally. Industry analysts have noted that IM8’s revenue velocity in its first six months exceeds typical benchmarks for successful supplement launches by 500%. The special announcement event at Wimbledon House featured Sabalenka alongside Prenetics executives, IM8’s Scientific Advisory Board members, including Dr. Dawn Mussallem from Mayo Clinic and Dr. Ara Suppiah, Functional Sports Physician, as well as media, and friends of the brand. The gathering highlighted the significance of this partnership as Sabalenka prepares for one of tennis’s most prestigious tournaments. IM8’s Daily Ultimate Essentials are available at www.im8health.com. Press Kit: HERE About PreneticsPrenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer health. Our consumer initiative is led by IM8, a fast-growing health and wellness brand, Europa, one of the largest sports distribution companies in the USA, and CircleDNA, a leading direct-to-consumer DNA test. As the first healthcare company to establish a Bitcoin treasury with its initial $20 million Bitcoin purchase and board-approved comprehensive Bitcoin strategy, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to “enhancing life through science”. To learn more please visit prenetics.com and IM8health.com About IM8IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature’s most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8’s flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a 100% owned subsidiary of Prenetics (NASDAQ:

LOS ANGELES, July 11, 2024 (GLOBE NEWSWIRE) — Prenetics, (NASDAQ: PRE) a leading health sciences company, is proud to announce that former international footballer, entrepreneur and philanthropist David Beckham has become a strategic investor in the business. Prenetics and Beckham will become co-founding partners of a new health and wellness brand, IM8, which will focus on cutting-edge consumer health products, with details to be announced at a later date. Beckham said, “Throughout my life and career, I’ve been fortunate to have access to the best medical professionals, nutrition experts and fitness coaches. Their guidance has been crucial to my health and well-being. That’s why I am excited to be working with Prenetics – a company that is dedicated to innovative, world-leading scientific advancements in health – as a co-founding partner and ambassador for IM8.” Danny Yeung, CEO and co-founder of Prenetics, welcomed David Beckham’s involvement: “This partnership with David marks a transformative era for Prenetics in global health innovation and wellness. David epitomizes the values of discipline, teamwork and health, aligning perfectly with Prenetics’ core principles. Working closely with David these past months, I’ve been consistently inspired by his vision for accessible health for all. His passion and commitment are truly extraordinary. With IM8, we have a unique opportunity to contribute meaningfully to the consumer health and wellness industry.” Beckham has also spent time with Prenetics shareholder, Professor Dennis Lo, during which he has been impressed to learn about Professor Lo’s pioneering discovery of non-invasive prenatal testing in 1997 and current focus on early cancer detection.  These conversations have highlighted the significant potential of Prenetics’ innovations to impact global health and longevity.  To learn more, join the waitlist at IM8health.com and follow IM8 Health on Instagram to stay updated. High-resolution images can be downloaded from:https://prenetics.com/IM8 Investor Relations Contact:Shannon DevineMZ North AmericaMain: 203-741-8811shannon.devine@mzgroup.us Angela CheungInvestor Relations / Corporate FinancePrenetics Global Limitedangela.hm.cheung@prenetics.com Ellen MarchantSenior Director, Communications for David Beckhamemarchant@authentic.com ABOUT PRENETICSPrenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand. Our clinical division is led by Insighta, our $200 million joint venture with renowned scientist Prof. Dennis Lo, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer comprehensive DNA tests. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’. ABOUT DAVID BECKHAMDavid Beckham, is one of England’s most successful footballers. With a career spanning 20 years, David has played with some of the most successful clubs in the world, including Manchester United and Real Madrid, as well as the England team, which he captained for six years. David was the first English player to have won league titles in four countries: England, Spain, the United States and France.   After retiring from playing in 2013, David established himself as a successful entrepreneur, working with many of the world’s leading brands including adidas, Stella Artois, Tudor, EA, and Nespresso.  In 2018, David fulfilled a life-long ambition to be an owner of a football club when his group was awarded the Major League Soccer Franchise for the city of Miami. Inter Miami CF was officially announced in September 2018 with David as President of the Club. In 2019, David founded his own content studio, Studio 99. The studio operates both editorial and commercial production, and specialises in developing and producing premium documentary features, series and formats for global platforms and networks, including Netflix and Disney+. In February 2022 Authentic Brands Group (Authentic), a unified platform that integrates M&A, brand strategy, creativity and digital innovation, announced that it had entered into a strategic partnership with David Beckham to co-own and manage Beckham’s global brand. In connection with the partnership, David Beckham became a shareholder in Authentic.  David Beckham joined a roster of Authentic’s growing entertainment portfolio that includes some of the world’s most celebrated athletes and iconic sports brands such as Shaquille O’Neal, Sports Illustrated, and Muhammad Ali. Throughout his life, David has been committed to supporting charities and projects that seek to drive change for the better. David has worked with UNICEF for nearly 20 years as a Goodwill Ambassador, a role that promotes and protects the rights of the world’s most vulnerable children. In 2015, David launched the 7 Fund with UNICEF – a unique partnership to give vulnerable and disadvantaged children the opportunity to reach their full potential. David also campaigns for Malaria No More, using his platform to ensure the world and its leaders hear the urgent message of the malaria fight. While, in his position as Ambassadorial President of the British Fashion Council (BFC), David helps promote and nurture British fashion and the UK’s creative industries.  ABOUT PROFESSOR DENNIS LOProfessor Dennis Lo is a world-renowned scientist, distinguished for his pioneering contributions to the field of medical research. Prof. Lo received his Bachelor of Arts degree from the University of Cambridge and the Doctor of Medicine and Doctor of Philosophy degrees from the University of Oxford. In 1997, his discovery of fetal DNA in maternal blood revolutionized prenatal testing, making it non-invasive. Today, this test is used annually by over 15 million expectant mothers in 90 countries worldwide. Prof. Lo is currently focused on a new breakthrough technology he founded called “FRAGMA”, aimed at early cancer detection. This innovation has the potential to significantly improve survival rates through earlier intervention. Prof. Lo has received numerous prestigious awards, including the King Faisal International Prize in Medicine in 2014, the Future Science Prize in 2016, the 2021 Breakthrough Prize in Life Sciences and the 2022 Lasker Award.

–  Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy’s ~$40B Bitcoin holdings and Metaplanet’s meteoric treasury transformation –  Following strategic divestiture, Prenetics leverages strengthened $117M balance sheet to execute comprehensive Bitcoin strategy with board-approved majority allocation, institutional financing partnerships, and alpha-generating initiatives. CHARLOTTE, N.C., June 18, 2025 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE), a leading health sciences company, today announced it has become the first healthcare company to establish a Bitcoin treasury, completing a $20 million Bitcoin purchase of 187.42 BTC at an average price of $106,712 per Bitcoin via a Kraken custody account. Concurrent with this groundbreaking treasury strategy, Prenetics announced the appointment of Andy Cheung, former COO of OKEx, to its Board of Directors, providing direct board-level oversight from one of the crypto industry’s most experienced executives. Prenetics plans to substantially increase its Bitcoin holdings and aims to become one of the largest healthcare corporate Bitcoin holders globally. Danny Yeung, CEO of Prenetics, said, “What excites me most is the convergence we’re witnessing between healthcare innovation and blockchain technology. We’re at the dawn of a new era where genomics, personalized medicine, and digital assets will intersect in ways that could revolutionize how we approach human health, longevity and wealth. To execute this vision at scale, we need substantial Bitcoin holdings – which is why we’re building one of the most significant Bitcoin treasuries in healthcare.” Andy Cheung Joins Board: Crypto Industry Titan Provides Strategic OversightThe appointment of Andy Cheung to the Board of Directors represents a strategic coup for Prenetics’ Bitcoin treasury initiative. Mr. Cheung, former COO of OKEx (now one of the world’s top-3 cryptocurrency exchanges) and current Co-Founder & CEO of both OEX and PredicXion, brings a decade of crypto exchange operations expertise, managing billions in daily trading volume. His appointment to the board provides unmatched operational guidance and governance for the company’s pioneering Bitcoin treasury strategy. “Having worked with Danny at Groupon Asia over a decade ago, I saw firsthand his ability to execute transformational strategies,” commented Andy Cheung. “I’m incredibly excited about the opportunity to contribute my crypto expertise to this pioneering healthcare Bitcoin strategy. I already have numerous ideas on accumulation strategies and alpha-generating approaches that can significantly outperform simple buy-and-hold tactics. This isn’t about passive Bitcoin storage – we’re talking about dynamic treasury management using derivatives, yield strategies, and institutional-grade trading techniques I’ve refined through managing billions in crypto exchange operations. The intersection of my crypto operational experience with Prenetics’ healthcare innovation creates unprecedented opportunities for value creation.” Professional Validation from Crypto Industry LeadersSupporting this groundbreaking strategy, Prenetics is guided by crypto industry’s most influential leaders: “We’ve assembled the architects of the crypto ecosystem,” said Danny Yeung, CEO of Prenetics. “Andy Cheung has moved more Bitcoin in a single day than most Fortune 500 companies will ever own. Tracy Hoyos Lopez has solved regulatory puzzles that have stumped entire governments. Raphael Strauch literally brings together every major crypto decision-maker on the planet at TOKEN2049. This isn’t just a team – it’s the concentrated intelligence and operational firepower of the entire digital asset revolution. While other healthcare companies are still figuring out what Bitcoin is, we’re building the infrastructure to dominate the intersection of health and digital wealth for the next decade. The question isn’t whether we’ll succeed – it’s how far ahead of everyone else we’ll be.” Tracy Hoyos Lopez added: “After successfully guiding President Trump’s Bitcoin advocacy and seeing the regulatory environment strengthen globally, Prenetics’ comprehensive Bitcoin strategy, now bolstered by their strengthened financial position, positions the company to benefit immensely from accelerating institutional adoption. Danny’s ambition is large – he’s not just building a Bitcoin treasury, he’s architecting the future intersection of healthcare and digital assets. Their accumulation plans and alpha-generating approach represents one of the most professionally thought out Bitcoin strategies I’ve seen and I’m proud to support and help on this exciting journey.” Raphael Strauch commented: “Through TOKEN2049, I’ve witnessed the evolution of institutional crypto adoption firsthand. And I’m incredibly excited to be part of Prenetics’ journey. Their comprehensive long-term Bitcoin strategy, represents the kind of bold, systematic, and expertly-governed approach that separates true industry leaders from followers. Their inspiration from MicroStrategy and Metaplanet, combined with their unique healthcare focus, positions them as a definitive pioneer in what I believe will be the next wave of corporate Bitcoin adoption.” Comprehensive Long-Term Bitcoin Strategy: Beyond Treasury HoldingsPrenetics’ Bitcoin initiative extends far beyond a simple treasury allocation, representing a comprehensive long-term digital asset strategy that includes: Board-Approved Majority Balance Sheet Allocation: The Board has approved allocating the majority of Prenetics’ balance sheet to Bitcoin, demonstrating unprecedented commitment to digital asset adoption within the healthcare sector. Institutional Capital Partnership Discussions: The company is actively in discussions with leading financial institutions to develop a comprehensive long-term Bitcoin acquisition plan. Alpha-Generating Strategies: Beyond holding Bitcoin, Prenetics will implement sophisticated alpha-generating strategies to maximize returns on its Bitcoin holdings, including yield generation, strategic lending, collateralization, and structured products. Operational Bitcoin Integration: Prenetics will soon accept cryptocurrency payments across both of its direct-to-consumer platforms, including IM8 Health and CircleDNA, creating a seamless Bitcoin ecosystem from treasury to operations. Strong Business Growth Fuel Bitcoin StrategyPrenetics’ strategic Bitcoin treasury initiative is underpinned by exceptional business performance. Management increased full-year 2025 revenue guidance to $80-100 million, demonstrating confidence in the core business trajectory, with profitability expected in Q4 2025. The growth is notably led by IM8 Health, which achieved extraordinary success in just six months since launch: Prenetics operates three complementary consumer health brands: IM8 (premium health supplements), CircleDNA (leading direct-to-consumer DNA testing), and Europa (one of the largest sports nutrition distribution companies in the United States). Enhanced Financial Position Enables Strategic InnovationPrenetics’ Bitcoin treasury strategy is supported by a significantly strengthened financial position: Elite Advisory Team: Trump Bitcoin Architect and TOKEN2049 Founder Provide Unmatched Credibility Tracy Hoyos Lopez – Chief of Staff for Strategic Initiatives at Kraken and Board Member of the Bitcoin Advocacy Project. A former prosecutor, Tracy gained international recognition as “the